Colorectal Neoplasm — SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
Citation(s)
A Randomized Phase II Study of Oxaliplatin and S-1 (SOX) Versus Oxaliplatin and Capecitabine (XELOX) in Patients With Peritoneal Metastasis of Colorectal Cancer